Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
RANK ligand and the regulation of skeletal remodeling
Norman H. Bell
Norman H. Bell
Published April 15, 2003
Citation Information: J Clin Invest. 2003;111(8):1120-1122. https://doi.org/10.1172/JCI18358.
View: Text | PDF
Commentary

RANK ligand and the regulation of skeletal remodeling

  • Text
  • PDF
Abstract

Authors

Norman H. Bell

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Regulation of osteoclast formation, function, and apoptosis by cytokines...
Regulation of osteoclast formation, function, and apoptosis by cytokines produced by bone marrow stromal cells, osteoblasts, monocytes, T cells, and B cells. Stimulatory factors are shown in orange and inhibitory factors in green. The effects of E to enhance (+) and inhibit (–) the factors are shown in red.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts